Abstract
Studies on Caenorhabditis elegans would benefit from the introduction of new selectable markers to allow more complex types of experiments to be conducted with this model animal. We established a new antibiotic selection marker for C. elegans transformation based on nourseothricin (NTC) and its resistance-encoding gene, streptothricin-acetyl transferase 2 (Sat2). NTC was able to efficiently prevent worm development at very low concentrations, and the worms expressing Sat2 were able to survive on the selection plates without any developmental defects. Using CRISPR/Cas9 and NTC selection, we were able to easily insert a 13-kb expression cassette into a defined locus in C. elegans. The structure and spectrum of NTC differs from other antibiotics like hygromycin B and geneticin, making it possible to use NTC alongside them. Indeed, we confirmed NTC-sat2 selection could work with the hygromycin B selection system simultaneously. Thus, the new NTC–Sat2 system can act as a useful dominant marker for gene transfer and genome editing in C. elegans.
Introduction
The nematode Caenorhabditis elegans has been used to study a broad spectrum of biological problems in many fields. One of the main reasons for the success of C. elegans as a model organism is the ease by which it undergoes gene transduction. Transgene expression in C. elegans is accomplished by microinjection of DNA into the gonads [1]. Several selectable genetic markers have been used [2]. Traditionally, transformed animals are identified by rescuing non-lethal mutations [3, 4] via the expression of a dominant phenotype marker [1] or a fluorescent marker [5, 6]. C. elegans can inherit DNA molecules injected into it as extrachromosomal arrays [7]. However, because extrachromosomal arrays tend to be inherited in only a subset of the progeny worms, it is difficult to grow large populations of transgenic strains. Moreover, to maintain the extrachromosomal array-carrying strains, researchers need to pick up individual worms one by one using readily distinguishable markers [1, 7].
Antibiotics and their corresponding resistance genes are now used widely as markers for gene transfer in many organisms such as bacteria and yeast, and in mammalian cells also. One advantage of these markers is that the transgene can be introduced into any genetic background. Antibiotic selection systems have been applied to worms as well, and some pairs of antibiotics and their resistance genes that work in nematodes have been reported (e.g. puromycin [8], geneticin (G418) [9], hygromycin B [10, 11] and blasticidin S [12]). Nevertheless, from the perspectives of cost, ease of use and efficiency, designing more transgenic markers would be very useful.
Nourseothricin (NTC), a member of the streptothricin class of aminoglycoside antibiotics, inhibits cellular protein synthesis by inducing miscoding [13]. Prokaryotic and eukaryote cells alike are efficiently killed by NTC. NTC and its associated resistance genes have already been used in bacteria, yeast, plants and mammalian cells as selection markers [14–16]. One of the NTC resistance genes, streptothricin acetyl transferase 2 (Sat2), was originally derived from a bacterial transposon, and confers streptothricin resistance to host strains [17]. Sat2 is a 174-amino-acid protein that inactivates the streptothricin class of aminoglycoside antibiotics, including NTC, by its N-acetyltransferase activity. As the structure and spectrum of NTC are totally different from other aminoglycoside antibiotics such as G418 or hygromycin B, Sat2 would not inactivate these antibiotics. Thus, Sat2 and the resistance genes for such drugs can be used simultaneously as selection markers in human cell cultures [16].
Genome editing by CRISPR/Cas9 has been widely used in the field of C. elegans genetics. A lot of genome editing techniques such as single copy insertion and homologous recombination rely on antibiotics selection [18, 19]. Therefore, the availability of additional selection markers that can be compatible with genome editing will enable more complex and innovative experimental designs to be considered by researchers.
In this study, we report that NTC and its resistance gene Sat2 can act together as a dominant selection marker for C. elegans transgenesis. In wild-type worms, growth and development were efficiently inhibited in the presence of NTC, whereas the Sat2-expressing worms were able to develop normally and reproduce on the selection medium. In terms of the price per experiment, the cost of this system is comparable to other antibiotic selection systems, making it a good choice for gene transfer in C. elegans. Notably, we have shown in our experiments that NTC selection is compatible with CRISPR/Cas9-mediated single-copy insertion, as revealed by cell-specific expression following insertion of an expression cassette of ~ 13-kb into a defined genomic locus. Moreover, we confirmed that our NTC-Sat2 selection system was also able to work with the hygromycin B selection system at the same time.
Materials and methods
Worm strains and maintenance
Wild-type C. elegans (N2 Bristol strain), obtained from the C. elegans Genetic Center (CGC) (https://cgc.umn.edu/), was grown in standard nematode growth medium (NGM) [20]. We used 60-mm plates containing 12 mL of NGM with 100 μl of OP50 feeder cultured on the NGM. All strains were maintained at 20°C. In addition to N2, the following strains were used in this study: OTL90: jpnSi5[[Punc-4c::Cre, Prps-0::Sat2, Pmig-13::loxP::STOP::loxP::sam-4::gfp] V], OTL94: jpnSi7 [[Punc-4c::Cre, Prps-0::Sat2, Pmig-13::loxP::STOP::loxP::tomm-20::gfp] V], OTL80: jpnSi1 [[Punc-4c::Cre, Prps-0::HygR, Pmig-13::loxP::STOP::loxP::tomm-20::gfp] II], OTL95: jpnEx65 [Pmyo-2::mCherry, Pmyo-3::mCherry, Prab-3::mCherry, Prps-27::Sat2], and OTL96: jpnEx66 [Pmyo-2::mCherry, Pmyo-3::mCherry, Prab-3::mCherry, Prps-27::Sat2].
Plasmid construction
PCR was performed using KOD-Plus-Neo (TOYOBO, Tokyo, Japan) following the manufacturer’s protocol. To generate Prps-27::Sat2 vector (pSN444, addgene ID 108331) and Prps-27::Nat vector, the codon-optimized NTC resistance genes Sat2 (GenBank: AKT95189.1) and nourseothricin acetyl transferase (Nat) (GenBank: AAC60439.1) were synthesized by Gene Art (Invitrogen, Carlsbad, CA, USA). The rps-27 promoter was obtained from pCFJ910 (a gift from Erik Jorgensen, Addgene#44481). The fragments were inserted into the ΔpSM vector (a generous gift from Dr. Kang Shen, Stanford University) using AscI/KpnI and SphI/AscI restriction enzyme sites.
To construct the pOB4_tomm-20 repair template vector, we first generated the pOB4 parental vector. To insert the expression cassette into the genome, we designed a Cas9 target site on chromosome II (position 8,420,204), the locus of which has been reported as the insertion site of ttTi5605 for mos1-mediated single-copy insertion (MosSCI) [21]. The Cas9 target site was chosen using the online design tool available at CRISPRdirect (http://crispr.dbcls.jp/) [22]. The target sequence is 5'-GATATCAGTCTGTTTCGTAACGG-3'. The underline shows the protospacer adjacent motif (PAM) sequence. As homology arms, 700–900 base pair (bp) DNA fragments were amplified by polymerase chain reaction (PCR) from the N2 genome using 5'-tcgacgcaagcttctccttc-3' (sense primer) and 5'-cgaaacagactgatatcgaaac-3' (antisense primer) for the left arm, and 5'-taacggtcttctgtataactac-3' (sense primer) and 5'-tggaggccttgttgtcgatc-3' (antisense primer) for the right arm. Punc-4c and Pmig-13::loxP::STOP::loxP have been described previously [23]. Prps-0::HygR::unc-54 3′UTR was amplified from pDD282 (a gift from Bob Goldstein, Addgene#66823 [18]). Punc-4c::Cre::tbb-2 3′UTR and Pmig-13::loxP::STOP::loxP::gfp::rab-3 3′UTR vectors were constructed and then assembled with the homology arms, Prps-0::HygR::unc-54 3’UTR and SacI-KpnI digested pBlueScript II KS(-) by the Gibson assembly method [24]. The tomm-20 fragment was PCR-amplified from worm cDNA and ligated to the SalI digested parental pOB4 plasmid using the Gibson assembly method. To construct the pOB5_sam-4 and pOB5_tomm-20 repair template vectors, we first generated the pOB5 parental vector by the same method described above for pOB4. The Cas9 target locus for pOB5 was designed for chromosome V (position 8,643,066), the locus of which has been reported as the insertion site of oxTi365 for universal MosSCI [25]. The Cas9 target site was also chosen using CRISPRdirect. The target sequence is 5'-CGGTCGCGGTACTCCAAATAGG-3'. The underline shows the PAM sequence. As homology arms, 700–900 bp DNA fragments were PCR-amplified from the WRM0613cH01 fosmid using 5'- agcgttgatgattggagggg-3' (sense primer) and 5'- cggtcgcggtactccaaat-3' (antisense primer) for the left arm, and 5'- aggcaggatattctccatttctga-3' (sense primer) and 5'- caaacaccacgcacattccc-3' (antisense primer) for the right arm. The tomm-20 fragment and sam-4 cDNA [26] were PCR-amplified and ligated to the SalI digested pOB5 construct using the Gibson assembly method.
pTK73_pOB4 and pTK73_pOB5 were used to express single guide RNA (sgRNA) for Cas9-mediated insertion by pOB4 and pOB5. To construct the pTK73_pOB4 and pTK73_pOB5 sgRNA-expressing vectors, we first generated the sgRNA(F+E)-expressing parental vector, pTK73 [27] [28]. The sgRNA(F+E) scaffold was introduced into pRB1017 (a gift from Andrew Fire, addgene#59936 [29]). The sgRNA(F+E) scaffold sequence was obtained by PCR and then ligated to XhoI-NheI digested pRB1017. The target sequence for Cas9-mediated insertion are 5'-GATATCAGTCTGTTTCGTAACGG-3' for pOB4 (chromosome II) and 5'-CGGTCGCGGTACTCCAAATAGG-3' for pOB5 (chromosome V) as described above. Underlines indicate PAM sequences. Therefore, the primers used to insert the Cas9 target sequence into pTK73_pOB4 comprised 5'-TCTTGatatcagtctgtttcgtaa-3' and 5'-AAACttacgaaacagactgatatC-3', whereas those for pTK73_pOB5 comprised 5'-TCTTGcggtcgcggtactccaaat-3' and 5'-AAACatttggagtaccgcgaccgC-3', all of which were commercially synthesized by Eurofin Genetics Japan (Tokyo, Japan). The primers were annealed and ligated to BsaI-digested pTK73 as described previously [29].
NTC survival assays
NTC was purchased from Jena Bioscience (Germany). We reconstituted the NTC powder in double-distilled water (DDW) to each concentration and stored the aliquots at −30°C. For the antibiotic selection experiments, the NTC solutions were added directly to the growth plates at final concentrations ranging from 0.02 mg/mL to 2.00 mg/mL (NTC weight/ NGM volume). The plates were air dried with their lids off. To determine the optimal concentration of NTC, we placed more than ten synchronized L1 worms or ten gravid young adult worms onto each selection plate concentration. The three plates prepared for each concentration were monitored for up to four days for the larvae or seven days for the adults.
NTC selection assays
To generate the Sat2-carrying extrachromosomal array strains, we injected 20 ng/μL of Prps-27::Sat2 vector (pSN444) with 60 ng/μl of pBlueScript II KS(-) and three mCherry markers [2.5 ng/μl of pCFJ90 (Pmyo-2::mCherry), 5.0 ng/μl of pCFJ104 (Pmyo-3::mCherry) and 10 ng/μl of pGH8 (Pmyo-3::mCherry), all of which were gifts from Erik Jorgensen Addgene #19327, #19328 and #193595 [6]], into the N2 worms. At the F1 generation, we picked up mCherry-positive worms under an SZX16 stereoscopic fluorescence microscope (Olympus, Tokyo, Japan). Lines stably expressing mCherry after the F2 generation were selected. For the enrichment experiments, we placed ten mCherry-positive adult worms onto NGM plates with or without 0.04 mg/ml of NTC. Two independent strains were tested on two plates each. After three days of incubation, the worms were transferred to new selection plates or non-selection plates by removing 25-mm2 of the gel from each plate. This procedure was repeated four times. After the final transfer, the effect of Sat2 expression was evaluated by calculating the ratio of mCherry-positive worms to the total number of worms.
NTC-Sat2-based selection combined with CRISPR/Cas9
CRISPR/Cas9-induced genome editing was performed as described previously [19] with one modification. Repair template vector (10 ng/μL; pOB5_sam-4), 50 ng/μL of sgRNA vector (pTK73_pOB5) and 50 ng/μL of pDD162 (Peft-3::Cas9, a gift from Bob Goldstein, Addgene #47549 [18]), were co-injected into the N2 worms with three mCherry markers [pCFJ90 (Pmyo-2::mCherry), pCFJ104 (Pmyo-3::mCherry) and pGH8 (Pmyo-3::mCherry)]. After injection, the P0 parents were placed on normal NGM plates with OP50 feeder and allowed to lay eggs. One day later, 500 μl of NTC solution was added directly to the plates at its optimal concentration (final 0.04 mg/mL, NTC weight/NGM volume) and the plates were allowed to dry. After 7–10 days of incubation at 20°C, either the extrachromosomal array-carrying worms (mCherry-positive) or the single-copy inserted worms (mCherry-negative) survived on the selection plates. Next, we picked up L4 or adult worms that looked healthy but lacked mCherry fluorescence (i.e. lacked the extrachromosomal array markers) under the stereoscopic fluorescence microscope and singled them out onto new nonselective NGM plates. Integration was checked by worm PCR, followed by observation of SAM-4::GFP using microscopy. The Tomm-20::GFP strain was obtained using the same stream.
Body bending assays
The thrashing rate assay was performed as described by Mikiro and Masaaki (2012) [30]. Young-adult worms (containing less than 7 eggs) were transferred to an NGM plate (φ = 35 mm) filled with 1mL of M9 buffer (3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 1 mL 1 M MgSO4 and H2O to 1 liter). To become accustomed to the environment, the worms were left for 1 min in the plates at room temperature. After that, we recorded worm bending movies for 1 min and counted the number of thrashes. Twenty worms per strain were used in each bending assay.
Double selection by NCT and hygromycin B
Hygromycin B Gold (solution) was purchased from nacalai tesque (Kyoto, Japan). Hygromycin B solution was diluted with DDW to a final concentration of 0.08 mg/mL (hygromycin B weight/ NGM volume) just before addition to the plates. Both NTC solution and hygromycin B solution were added directly to the NGM plates already seeded with OP50. The OTL80 strain with hygromycin B resistance (integrated HygR with tomm-20::gfp in chromosome II) was used. Male OTL80 worms were crossed with OTL90 (integrated Sat2 with sam-4::gfp in chromosome V) hermaphrodite worms and F1 worms were obtained. We put 10 young adult F1 worms onto each selection plate containing NTC and/or hygromycin B. After 3 days incubation, we checked the SAM-4::GFP and TOMM-20::GFP signals from the F2 worms and calculated the ratio for each worm.
Microscopy
The worm images on the plates were acquired using an SZX16 stereoscopic fluorescence microscope (Olympus) equipped with a CoolSNAP HQ cooled-CCD camera (Photometrics, Tucson, AZ, USA). Before image acquisition, the plates were cooled at −30°C for 1 min to prevent worm movements. For the fluorescence imaging of the sam-4::gfp integrated worms, we used an ORCA-R2 digital CCD camera (Hamamatsu Photonics, Hamamatsu, Japan) on an IX71 microscope (Olympus) with an UPlanSApo 60x/ NA1.3 silicone oil objective lens (Olympus) and a CSU-X1 spinning disc confocal system (Yokogawa Electric Corporation, Tokyo, Japan). Worms were mounted onto 3% agar pads with 2.5mM levamisol in M9 buffer, as described previously [31]. MetaMorph software (Molecular Devices, Sunnyvale, CA, USA) was used to control both microscopes. Fluorescent images of the worms were taken with 40 Z-slices and 1 μm intervals. ImageJ (NIH, https://imagej.nih.gov/ij/index.html) was used to process the images acquired.
Worm PCR
To confirm that the genome editing occurred successfully at the proper locus, we performed worm PCR using the following primer pairs: P1: 5'-cgtcggcatcacaaggaatg-3', P2: 5'-tcatcacttgtcgcgtcaac-3', P3: 5'-agttatcgctagcagggcac-3' and P4: 5'-cgtcggcatcacaaggaatg-3'.
Ten adult worms were picked into 10 μl of lysis solution (10mM Tris-HCl, pH 8.2; 50mM KCl, 2.5mM MgCl2, 0.45% NP40, 0.45%Tween 20, 0.01% gelatin, and 0.5 mg/mL proteinase K) to extract their genomic DNAs. After one h digestion at 60 °C, the solutions were heated to 90°C for 15 min to inactivate the proteinase K. These solutions were then used directly as the PCR templates. Takara Ex Taq was used as described in the manufacturer’s protocol for the PCRs (Takara, Tokyo, Japan).
Statistics
Statistical analyses were performed by using GraphPad PRISM 7 (GraphPad, La Jolla, CA, USA) on Mac OSX (Apple Inc., Cupertino, CA, USA). Statistical methods and sample numbers are clearly described in each graph or figure legends.
Results
The NTC-resistance gene Sat2 works as a selection marker in C. elegans
In the search for alternative antibiotics and antibiotic resistance genes that can be applied to C. elegans genetics, we found that NTC can kill wild-type worms efficiently (Fig 1). The young larvae were found to be more sensitive to NTC than the adult worms, perhaps because they need more rapid protein synthesis for development. In C. elegans transformations, DNA is injected into the gonads of the parental worms and the next generation is scored [1]. Thus, to obtain as many transgenic progenies as possible, the adult worms need to live until they stop laying eggs, while larvae are unable to develop on the selection plate. At 0.04 mg/mL (NTC weight/NGM volume), growth of wild-type larvae was completely stopped, while adult worms could live for several days. Thus, we defined that 0.04 mg/mL is the optimal quantity of NTC to use in the experiments (Fig 1A and 1B).
We next tested two NTC resistance genes, Sat2 and Nat, as potential selection markers for C. elegans transformation [14, 16]. In order to express these genes in C. elegans, Sat2 and Nat were codon optimized using a C. elegans codon adaptor [32] (https://worm.mpi-cbg.de/codons/cgi-bin/optimize.py) and then synthesized. As seen with other drug-resistance genes, Sat2 and Nat are each expressed under the control of a universal promoter for the ribosomal protein encoding gene, rps-27 [8] [9] (Fig 2A). We injected Prps-27::Sat2 or Prps-27::Nat vectors, which each contain three visible mCherry fluorescence markers [pCFJ90 (Pmyo-2::mCherry), pCFJ104 (Pmyo-3::mCherry) and pGH8 (Pmyo-3::mCherry)], into N2 worms and obtained transgenic strains that contained the extrachromosomal arrays. Using mCherry as a visible marker, we placed ten extrachromosomal array-positive worms per strain onto selection plates. Subsequently, the Sat2-expressing worms but not the Nat-expressing worms survived on NGM agar containing NTC. As we were unsure of the exact reason why Nat was ineffective in the worms, we focused our efforts on Sat2 thereafter.
Extrachromosomal arrays become lost from the germ line at various frequencies. Thus, if extrachromosomal array-containing worms are not selected, the arrays are often lost after several generations. Therefore, to test whether Sat2 is useful for maintaining the extrachromosomal arrays, we performed the following experiment. The extrachromosomal array-positive worms were placed onto selective or non-selective plates. When the plates became starved, the worms were transferred to new selection or non-selection plates by cutting the gel containing them off by 25 mm2. We repeated this procedure four times. After the final transfer, the maintenance of the extrachromosomal arrays was evaluated by calculating the ratio of mCherry-positive worms to total worm numbers (Fig 2B and 2C). When the worms were cultured on plates lacking NTC, the average ratio of the transgenic worms was 7.5% of the total worms. However, when the worms were cultured on the selection plates, almost all the worms had mCherry signals (Fig 2C), indicating that NTC and Sat2 helped to enrich the population of the extrachromosomal array strains.
NTC selection is useful for Cas9-mediated single-copy insertion
CRISPR/Cas9-based genome engineering is performed widely in C. elegans [18, 29]. Several pairs of antibiotics and their cognate resistance genes have been used as positive selection markers in genome editing [12, 19, 33]. Here, we tested whether NTC-based selection can be reliably used for Cas9-mediated single-copy insertion. To avoid any side effects associated with insertion, we inserted the expression cassette into the well-characterized locus used for universal MosSCI [25]. A previous study exploited genomic position 8,420,204 of chromosome II (the locus for ttTi560) for Cas9-triggered, single-copy insertion [21]; however, we found that the transgene’s expression level was higher when inserted into chromosome V at position 8,643,066 (the locus for oxTi365) (data not shown). We tried to visualize the SAM-4 synaptic vesicle marker, which is fused to the green fluorescent protein (GFP) [26]. To achieve DA9-neuron-specific dominant expression, we employed a previously described strategy involving Cre-loxP [23]. The unc-4c promoter (Punc-4c) is a DA-neuron-specific promoter, whereas the mig-13 promoter (Pmig-13) is a DA9- and VA12- dominant promoter. Thus, if Pmig-13::loxP::STOP::loxP::sam-4::gfp and Punc-4c::Cre are co-expressed, SAM-4::GFP should be detected only in the DA9 neuron in the tail region of the worms (Fig 3A). We attempted to insert both fragments into the same locus using CRISPR/Cas9 and NTC selection. We injected the repair template (pOB5_sam-4) together with the Cas9-encoding vector (pDD162), guide RNA expression vector (pTK73_pOB5) and mCherry vectors (pCFJ90, pCFJ104 and pGH8) (Fig 3B) into the N2 worms, after which they were allowed to lay eggs at 20°C. The next day, NTC solution was added to the plates at 0.04 mg/mL (weight of NTC/volume of NGM agar). One week after the injections, only the transgenic worms (either the single-copy inserted worms or the extrachromosomal array-positive worms) had survived on the selection plates. We isolated the L4/adult worms that showed NTC resistance but did not display mCherry expression (a marker for the extrachromosomal arrays) (Fig 3C). Note that the isolated worms are sometimes still heterozygous, therefore, we cloned out worms in the next generation to obtain homozygous worms. Integration was confirmed by worm PCR, followed by microscopic observation of SAM-4::GFP (Fig 4A and 4B). As anticipated, SAM-4::GFP was observed specifically in the DA9 neuron around the tail region (Fig 4C). These results suggest that NTC selection is useful for Cas9-mediated single copy insertion. Using the same strategy, we generated the DA9-specific mitochondrial marker as well (Fig 4D). To test whether Sat2 expression causes some side effects in worms, we counted the total number of progeny and the bending rate of the two established lines; however, there were no statistically significant differences between N2 and each of the two strains (Fig 4E and 4F). These results suggest that Sat2 expression has no significant influence on worm health.
NTC and hygromycin B selection systems can be used at the same time
The several antibiotic selection systems established to date include puromycin [8], geneticin (G418) [9], hygromycin B [10, 11] and blasticidin S [12]. More and more strains have been generated recently using antibiotic resistance markers, making it possible that in the near future researchers will have the opportunity to cross two strains carrying different antibiotic resistant genes. Here, we focused on widely-used hygromycin B and its resistance gene HygR, and tested whether our NTC-Sat2 system can be used with the hygromycin B system. We generated the HygR-carrying integration strain in the same way as for Sat2, but the inserted marker and insertion locus was changed to TOMM-20::GFP and chromosome II respectively (Fig 5A). This strain also displays TOMM-20::GFP in a DA9-specific manner. The workflow for the combination assay is described in Fig 5B. First, we crossed male OTL80 [HygR, tomm-20::GFP II] worms with hermaphrodite OTL90 [Sat2, sam-4::STOP::gfp V] worms to obtain the F1 generation, which carried both HygR and Sat2. Observing the GFP signals led to easily identifiable crossed or self-fertilized worms. The L4 stages of the F1 worms carrying both HygR and Sat2 were transferred onto three different types of antibiotic plates: (i) NTC only, (ii) hygromycin B only, or (iii) both NTC and hygromycin B. NTC and hygromycin B solutions were added to the plates at 0.04 mg/mL and 0.08 mg/mL (weight of antibiotic/ volume of NGM agar), respectively. When both antibiotic screening systems work well, the resulting F2 adult worms on each selection plate will carry their respective antibiotics resistance genes. We observed the GFP signals from the F2 worms as an indicator of resistance genes. Having TOMM-20::GFP (T) indicates that the worms are also carrying HygR, whereas having SAM-4::GFP (S) indicates they are carrying Sat2. If the hygromycin B selection and the NTC selection work independently, the ratio of the F2 phenotype should be as follows: [T; S]: [+; S]: [T; +] = (i) 1: 0: 0, (ii) = 3: 1: 0, (iii) = 3: 0: 1 (Fig 5B). In fact, as a result of this genetic experiment, phenotype ratios were almost the same as expected: (i) = 1: 0: 0, (ii) = 2.99: 1: 0, (iii) = 2.83: 1: 0 (Fig 5C). Worms carrying only Sat2 were not observed on hygromycin B plates while those carrying only HygR were not observed on NTC plates. Only worms that have both Sat2 and HygR were expanded on plates containing both Hygromycin B and NTC. This result indicates that NTC-Sat2 selection can therefore be used with hygromycin B-HygR selection at the same time.
Summary and discussion
In this study, the NTC–Sat2 selection system was established as a dominant selection tool for C. elegans transgenesis and genome editing. NTC treatment was able to effectively prevent wild-type worm development. Notably, the wild-type worms were unable to survive in the presence of only 0.04 mg/mL of NTC, while the Sat2-carrying transgenic worms reproduced. Sat2 is a small protein and did not cause defects in reproduction and movement in the worms (Fig 4E and 4F). We have succeeded in maintaining the extrachromosomal array in the strains for over three months on NTC plates without seeing any phenotypic abnormalities. However, we are unable to conclude that long term exposure to NTC will not have any detrimental effects while this is also the case in other antibiotics. Thus, for researchers wanting to use these strains in different experiments, we recommend they should be reared for at least one generation on normal NGM plates before use. For these experiments, some visible markers need to be included to pick up extrachromosomal-array carrying worms. The NTC–Sat2 selection system is useful not only for maintaining an extrachromosomal array (Fig 2) but also for Cas9-mediated single-copy insertion (Figs 3 and 4). Heterozygous worms with a single copy Prps-0::Sat2 could survive on NTC plates, indicating that even a single copy of Sat2 can confer sufficient NTC resistance. Although the price of NTC is much more expensive ($257/g at Gold Biotechnology, St. Louis, MO) than other antibiotics such as geneticin ($28/g) and hygromycin B ($64/g), the cost of NTC selection is comparable to these widely-used antibiotics because NTC is effective at much lower concentrations (the effective concentrations are 0.04 mg/ml, 1.6 mg/ml and 0.25 mg/ml for NTC, geneticin [9] and hygromycin B [10], respectively). Since drug selection in C. elegans was established, many strains have been generated that contain drug-resistance markers. For some experiments, researchers need to generate transgenic worms in these backgrounds. As Sat2 specifically inactivates the streptothricin-class of aminoglycoside antibiotics via its acetyltransferase activity, NTC should be used together with puromycin [8], neomycin [9], hygromycin B [10, 11] or blasticidin S selection [12, 16]. In this study, we only showed the NTC-hygromycin B pair (Fig 5), but other combinations could be also used, thereby facilitating more complex experimental designs to be undertaken in C. elegans. While this study has focused on NTC selection based on plate culture alone, the NTC–Sat2 system will also be applicable to liquid culture protocols for expanding a large population of transgenic worms.
CRISPR/Cas9-mediated genome editing, a powerful tool in C. elegans genetics, has elucidated a broad range of biological phenomena in vivo [18, 19, 34]. The DA9 neuron is a good model for studying neuronal morphogenesis and axonal transport [26, 35–37]. In order to visualize organelle markers in a DA9-dominant manner, previous studies have used complex genetic systems combining single-copy insertion of Punc-4::Cre and extrachromosomal arrays that have Pmig-13::loxP::STOP::loxP, both of which require laborious work for the genetic experiments [23, 38]. In contrast, we were able to successfully insert both Pmig-13::loxP::STOP::loxP::sam-4::gfp, a synaptic vesicle marker, and Punc-4::Cre into the same locus using Cas9-mediated single-copy insertion with NTC selection. This system would make it possible to analyze other organelles by changing the markers. In fact, using the same strategy, we obtained a DA9-specific mitochondrial marker as well (Fig 4D). Moreover, monitoring cell-specific expression would be possible in other neurons using different promoter combinations.
In conclusion, as a dominant marker for gene transfer in C. elegans, the NTC–Sat2 system offers many advantages to researchers.
Acknowledgments
The authors wish to thank members of the Sugimoto laboratory at Tohoku University, Japan. We also thank Sandra Cheesman, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. The N2 strain was provided by the CGC, which is funded by the NIH Program P40 OD010440.
Data Availability
All relevant data including vectors, primers, guide RNA sequence for genome editing, strains, are within the paper.
Funding Statement
This work was supported by the Japan Society for the Promotion of Science, Grant numbers: 16H06536 and 17H05010 (https://www.jsps.go.jp); the Naito Foundation (https://www.naito-f.or.jp/jp/index.php); and the Brain Science Foundation (http://www.bs-f.jp/kenjo.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 1991;10(12):3959–70. Epub 1991/12/01. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Giordano-Santini R, Dupuy D. Selectable genetic markers for nematode transgenesis. Cell Mol Life Sci. 2011;68(11):1917–27. Epub 2011/03/25. doi: 10.1007/s00018-011-0670-1 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Maduro M, Pilgrim D. Identification and cloning of unc-119, a gene expressed in the Caenorhabditis elegans nervous system. Genetics. 1995;141(3):977–88. Epub 1995/11/01. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Granato M, Schnabel H, Schnabel R. pha-1, a selectable marker for gene transfer in C. elegans. Nucleic Acids Res. 1994;22(9):1762–3. Epub 1994/05/11. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gu T, Orita S, Han M. Caenorhabditis elegans SUR-5, a novel but conserved protein, negatively regulates LET-60 Ras activity during vulval induction. Mol Cell Biol. 1998;18(8):4556–64. Epub 1998/07/22. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Frokjaer-Jensen C, Davis MW, Hopkins CE, Newman BJ, Thummel JM, Olesen SP, et al. Single-copy insertion of transgenes in Caenorhabditis elegans. Nat Genet. 2008;40(11):1375–83. Epub 2008/10/28. doi: 10.1038/ng.248 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Stinchcomb DT, Shaw JE, Carr SH, Hirsh D. Extrachromosomal DNA transformation of Caenorhabditis elegans. Mol Cell Biol. 1985;5(12):3484–96. Epub 1985/12/01. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Semple JI, Garcia-Verdugo R, Lehner B. Rapid selection of transgenic C. elegans using antibiotic resistance. Nat Methods. 2010;7(9):725–7. Epub 2010/08/24. doi: 10.1038/nmeth.1495 . [DOI] [PubMed] [Google Scholar]
- 9.Giordano-Santini R, Milstein S, Svrzikapa N, Tu D, Johnsen R, Baillie D, et al. An antibiotic selection marker for nematode transgenesis. Nat Methods. 2010;7(9):721–3. Epub 2010/08/24. doi: 10.1038/nmeth.1494 . [DOI] [PubMed] [Google Scholar]
- 10.Radman I, Greiss S, Chin JW. Efficient and rapid C. elegans transgenesis by bombardment and hygromycin B selection. PLoS One. 2013;8(10):e76019 Epub 2013/10/17. doi: 10.1371/journal.pone.0076019 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Namai S, Sugimoto A. Transgenesis by microparticle bombardment for live imaging of fluorescent proteins in Pristionchus pacificus germline and early embryos. Dev Genes Evol. 2018. Epub 2018/01/22. doi: 10.1007/s00427-018-0605-z . [DOI] [PubMed] [Google Scholar]
- 12.Kim H, Ishidate T, Ghanta KS, Seth M, Conte D Jr., Shirayama M, et al. A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans. Genetics. 2014;197(4):1069–80. Epub 2014/06/01. doi: 10.1534/genetics.114.166389 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Haupt I, Hubener R, Thrum H. Streptothricin F, an inhibitor of protein synthesis with miscoding activity. J Antibiot (Tokyo). 1978;31(11):1137–42. Epub 1978/11/01. . [DOI] [PubMed] [Google Scholar]
- 14.Goldstein AL, McCusker JH. Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast. 1999;15(14):1541–53. Epub 1999/10/09. doi: 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K . [DOI] [PubMed] [Google Scholar]
- 15.Ramos B, Gonzalez-Melendi P, Sanchez-Vallet A, Sanchez-Rodriguez C, Lopez G, Molina A. Functional genomics tools to decipher the pathogenicity mechanisms of the necrotrophic fungus Plectosphaerella cucumerina in Arabidopsis thaliana. Mol Plant Pathol. 2013;14(1):44–57. Epub 2012/09/04. doi: 10.1111/j.1364-3703.2012.00826.x . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kochupurakkal BS, Iglehart JD. Nourseothricin N-acetyl transferase: a positive selection marker for mammalian cells. PLoS One. 2013;8(7):e68509 Epub 2013/07/19. doi: 10.1371/journal.pone.0068509 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tietze E, Brevet J. Nucleotide sequence of the streptothricin-acetyl-transferase gene sat-2. Nucleic Acids Res. 1990;18(5):1283 Epub 1990/03/11. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dickinson DJ, Ward JD, Reiner DJ, Goldstein B. Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Methods. 2013;10(10):1028–34. Epub 2013/09/03. doi: 10.1038/nmeth.2641 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dickinson DJ, Pani AM, Heppert JK, Higgins CD, Goldstein B. Streamlined Genome Engineering with a Self-Excising Drug Selection Cassette. Genetics. 2015;200(4):1035–49. Epub 2015/06/06. doi: 10.1534/genetics.115.178335 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. Epub 1974/05/01. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Frokjaer-Jensen C, Davis MW, Ailion M, Jorgensen EM. Improved Mos1-mediated transgenesis in C. elegans. Nat Methods. 2012;9(2):117–8. Epub 2012/02/01. doi: 10.1038/nmeth.1865 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Naito Y, Hino K, Bono H, Ui-Tei K. CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinformatics. 2015;31(7):1120–3. Epub 2014/11/22. doi: 10.1093/bioinformatics/btu743 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Maeder CI, San-Miguel A, Wu EY, Lu H, Shen K. In vivo neuron-wide analysis of synaptic vesicle precursor trafficking. Traffic. 2014;15(3):273–91. Epub 2013/12/11. doi: 10.1111/tra.12142 . [DOI] [PubMed] [Google Scholar]
- 24.Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA 3rd, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343–5. Epub 2009/04/14. doi: 10.1038/nmeth.1318 . [DOI] [PubMed] [Google Scholar]
- 25.Frokjaer-Jensen C, Davis MW, Sarov M, Taylor J, Flibotte S, LaBella M, et al. Random and targeted transgene insertion in Caenorhabditis elegans using a modified Mos1 transposon. Nat Methods. 2014;11(5):529–34. Epub 2014/05/14. doi: 10.1038/nmeth.2889 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Niwa S, Tao L, Lu SY, Liew GM, Feng W, Nachury MV, et al. BORC Regulates the Axonal Transport of Synaptic Vesicle Precursors by Activating ARL-8. Curr Biol. 2017;27(17):2569–78 e4. Epub 2017/08/22. doi: 10.1016/j.cub.2017.07.013 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li GW, et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell. 2013;155(7):1479–91. Epub 2013/12/24. doi: 10.1016/j.cell.2013.12.001 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ward JD. Rapid and precise engineering of the Caenorhabditis elegans genome with lethal mutation co-conversion and inactivation of NHEJ repair. Genetics. 2015;199(2):363–77. Epub 2014/12/11. doi: 10.1534/genetics.114.172361 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Arribere JA, Bell RT, Fu BX, Artiles KL, Hartman PS, Fire AZ. Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans. Genetics. 2014;198(3):837–46. Epub 2014/08/28. doi: 10.1534/genetics.114.169730 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Nawa M, Matsuoka M. The Method of the Body Bending Assay Using Caenorhabditis elegans bio-protocol. 2012;2(17). doi: 10.21769/BioProtoc.253 [Google Scholar]
- 31.Niwa S. Immobilization of Caenorhabditis elegans to Analyze Intracellular Transport in Neurons. J Vis Exp. 2017;(128). Epub 2017/11/21. doi: 10.3791/56690 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Redemann S, Schloissnig S, Ernst S, Pozniakowsky A, Ayloo S, Hyman AA, et al. Codon adaptation-based control of protein expression in C. elegans. Nat Methods. 2011;8(3):250–2. Epub 2011/02/01. doi: 10.1038/nmeth.1565 . [DOI] [PubMed] [Google Scholar]
- 33.Norris AD, Kim HM, Colaiacovo MP, Calarco JA. Efficient Genome Editing in Caenorhabditis elegans with a Toolkit of Dual-Marker Selection Cassettes. Genetics. 2015;201(2):449–58. Epub 2015/08/02. doi: 10.1534/genetics.115.180679 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Niwa S, Lipton DM, Morikawa M, Zhao C, Hirokawa N, Lu H, et al. Autoinhibition of a Neuronal Kinesin UNC-104/KIF1A Regulates the Size and Density of Synapses. Cell Rep. 2016;16(8):2129–41. Epub 2016/08/16. doi: 10.1016/j.celrep.2016.07.043 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Klassen MP, Wu YE, Maeder CI, Nakae I, Cueva JG, Lehrman EK, et al. An Arf-like small G protein, ARL-8, promotes the axonal transport of presynaptic cargoes by suppressing vesicle aggregation. Neuron. 2010;66(5):710–23. Epub 2010/06/16. doi: 10.1016/j.neuron.2010.04.033 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yogev S, Cooper R, Fetter R, Horowitz M, Shen K. Microtubule Organization Determines Axonal Transport Dynamics. Neuron. 2016;92(2):449–60. Epub 2016/10/21. doi: 10.1016/j.neuron.2016.09.036 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Mizumoto K, Shen K. Two Wnts instruct topographic synaptic innervation in C. elegans. Cell Rep. 2013;5(2):389–96. Epub 2013/10/22. doi: 10.1016/j.celrep.2013.09.011 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yogev S, Maeder CI, Cooper R, Horowitz M, Hendricks AG, Shen K. Local inhibition of microtubule dynamics by dynein is required for neuronal cargo distribution. Nat Commun. 2017;8:15063 Epub 2017/04/14. doi: 10.1038/ncomms15063 . [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All relevant data including vectors, primers, guide RNA sequence for genome editing, strains, are within the paper.